To address the effect of ROCK on HIV-1 Tat-caused changes of ZO-1 and occludin protein in vivo, the ROCK-specific inhibitor HF was administered 30 min before being applied to HIV-1 Tat once a day for seven consecutive days. The gene discussed is TJP1; the disease is hydrops fetalis.